PATENT CLAIM ANALYSIS

Application Number: 16282120
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["424", "145100"]

Abstract:
Methods are disclosed for treating osteoarthritis in a human subject in need thereof, comprising administering to the subject a therapeutically effective amount of an anti-human NGF antibody, or antigen-binding fragment thereof, wherein at least one symptom associated with osteoarthritis is prevented, ameliorated or improved.

Claim (Index 19):
The injectable formulation of  claim 18 , wherein the human antibody or antigen-binding fragment thereof comprises a heavy chain variable region (HCVR) selected from the group consisting of SEQ ID NO: 100 and 108.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 99.0
- Lexical Diversity: 1.225
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14038349', '13648477', '12888751', '15144574', '12188330']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8328329977866457
- 35 USC 102 Novelty (BERT): 0.586512015814932
- Combined Prediction Score: 0.8082008995894743
- Mean Citation Score: 529.2572640000002
- Max Citation Score: 573.95435
- Similarity Product: 388.273767513892

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test